We develop innovative solutions in bioprocess technology for Biotech and BioPharma development digitalization and automation. Securecell is developing Seraccess, an innovative technology for the fully automated, high-frequency automatic on-line collection, processing, and analysis of minute quantities of blood for the monitoring and control of critical blood parameters.
Bioprocess development with full lab automation
Disruptive Glucose-Monitoring
See how our products seamlessly integrate with your current systems. Apply for a live demo with our experts.
Bioprocess laboratories with multiple lab-scale bioreactors often execute cultivation experiments in parallel with varying process parameters for process development and optimization purposes. A challenge in bioprocess development is the integration and automation of all process equipment and analyt...
Every biopharmaceutical process aims for real-time monitoring and control of critical process parameters to minimize process variability and at the same time ensure predefined product quality. High-frequency automated sampling from different bioreactors and sample transfer to state-of-the-art analyt...
A Feasibility Study Characterizing the Automated Glucose Measurement (AGM) Presented at the ATTD Advanced Technologies & Treatments for Diabetes Conference, 27–30 April 2022, Barcelona (& online) Keywords: Automatic glucose monitor, AGM, Artificial Pancreas Device System, APDS Backgr...
Real-time monitoring of antibody quality attributes for cell culture production processes in bioreactors via integration of an automated sampling technology with multi-dimensional liquid chromatography mass spectrometry A recently published article in the Journal of Chromatography A (Volume 1672...
In 2021 Securecell engaged with Amyris, a biotechnology company headquartered in Emeryville, California and publicly traded under $AMRS on Nasdaq. Amyris uses its fermentation platform to engineer and develop sustainable ingredients; these are used by a number of leading commercial partners and are ...
